Comparison · NCT02096029-sae
Standard Care + Nicotine Replacement Therapy (NRT) vs Standard Care: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Standard Care + Nicotine Replacement Therapy (NRT) vs Standard Care: serious adverse events. Trial comparisons, record NCT02096029-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02096029-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0152 | 0.008 | 0.0286 | wilson | |
| Risk in group 2 | 0.0307 | 0.0199 | 0.0469 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0155 | -0.0332 | 0.00168 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.495 | 0.227 | 1.08 | log | |
| Odds ratio, group 1 over group 2 | 0.487 | 0.22 | 1.08 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Standard Care + Nicotine Replacement Therapy (NRT) than on Standard Care | 64.5 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: standard care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Standard Care + Nicotine Replacement Therapy (NRT) | 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)~Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch | 9 | 593 | EG001 |
| Group 2 | Standard Care | Ask, Advise, Refer (physician brief advice) | 20 | 652 | EG000 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- Study consists of 3 follow-up phone calls at 1 month, 3 months, and 6 months post-baseline clinic visit. Adverse events are asked systematically of both groups, at all three follow-up calls.
Source ClinicalTrials.gov
Trial
- Title
- Tobacco Intervention in Primary Care Treatment Opportunities for Providers
- NCT number
- NCT02096029
- Phases
- NA
- Conditions
- Smoking, Smoking Cessation
- Interventions
- Nicotine Replacement Therapy (NRT) Sampling, Ask, Advise, Refer (physician brief advice)
- Lead sponsor
- Medical University of South Carolina
- Results first posted
- 2019-08-07
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02096029?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02096029-sae